Menu
GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Unit (HTAU)
    • Road to HTA Institutionalization
  • Issuances
  • Assessments
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Careers
    • Contact Us
    • Events Calendar
    • Call for Proposals
  • AUXILIARY MENU
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Unit (HTAU)
    • Road to HTA Institutionalization
  • Issuances
  • Assessments
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Careers
    • Contact Us
    • Events Calendar
    • Call for Proposals

effectiveness and safety of pazopanib in the management of metastatic soft tissue sarcoma post-chemotherapy

Annex A/Evidence Summary: http://bit.ly/ESPazopanibAnnexA

Advisory: http://bit.ly/AdvisoryPazopanib

 

DOCUMENT PREVIEW:

Advisory-Preliminary-HTAC-Recommendation-on-pazopanib-for-mSTS-23-February-2021

070030
Users Today : 296
This Month : 4963
Total Users : 70030
Your IP Address : 44.192.10.166
Philippine Standard Time: